Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Researchers link high-volume listening habits to future hearing damage in young people

3

Oct 2025

Researchers link high-volume listening habits to future hearing damage in young people

Music is more of a personal experience for young people and plays a significant role in their well-being and emotional regulation. However, using headphones almost around the clock risks leading to hearing damage. Research at Orebro University lends support to initiatives to raise awareness about high sound levels and the problems this may cause for society in the future.

Genetic and behavioral link found between musicality and language skills

3

Oct 2025

Genetic and behavioral link found between musicality and language skills

In a paper published in Nature Communications, researchers at Vanderbilt University Medical Center's Department of Otolaryngology-Head and Neck Surgery leveraged two main studies - one focused on behavior and one focused on genetics - to highlight the correlation between participants' musical rhythm abilities and developmental speech-language disorders.

Bio-Rad extends partnership with Gencurix through strategic agreement for Droplet Digital™ PCR IVD oncology kits in Europe

3

Oct 2025

Bio-Rad extends partnership with Gencurix through strategic agreement for Droplet Digital™ PCR IVD oncology kits in Europe

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, and Gencurix, Inc., a leading Korean developer of oncology testing solutions, today announced the signing of a strategic agreement establishing Bio-Rad as the exclusive distributor of Gencurix' CE-IVD Droplex™ digital PCR oncology testing kits throughout Europe.

Study uncovers cerebellar involvement and social impairment

3

Oct 2025

Study uncovers cerebellar involvement and social impairment

Spinal muscular atrophy is a rare genetic disease of the nerve cells in the spinal cord that can appear as early as infancy. The disease leads to a progressive loss of muscle strength. Those affected often suffer from muscle weakness early on, as well as difficulties with movement, breathing, and swallowing.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.